NewswireToday - /newswire/ -
Waukesha, WI, United States, 2011/08/30 - GE’s PET/CT +MR technology may hold promise in management of cancer, neurodegenerative and cardiac diseases - GEhealthcare.com. NYSE: GE
Hong Kong Sanatorium & Hospital (HKSH) has selected GE Healthcare’s tri-modality imaging solution—PET/CT+MR—which may potentially enhance the ability of physicians to manage certain diseases.
Dr. Walton Li, Medical Superintendent of HKSH, emphasized the hospital’s commitment to medical research in the interest of patients and to advance treatment. “HKSH is not only a hospital that serves patients, but one that is committed to research and to the advancement of medical technology,” explained Li.
The future of PET/CT imaging is in therapy monitoring. Rather than just imaging the patient at the beginning and end of a chemotherapy treatment, physicians may be monitoring patients more frequently to determine how well the treatment is working—whether the tumor trends are going down or up. The combination of superb soft tissue contrast of MR (magnetic resonance), the metabolic insight of PET (positron emission tomography) and the precise anatomical reference of CT (computed tomography), enabled by a patient transport system and image fusion, may hold promise for managing patient care.
“We are excited to deliver this system to Hong Kong Sanatorium & Hospital,” said Terri Bresenham, vice president and general manager Molecular Imaging GE Healthcare. “Our approach to PET/CT+MR is to harness the power of two proven technologies to provide researchers the superb quality clinical information they expect. At the same time, this fiscally responsible system allows a long lifecycle and efficient use of high value assets for routine standalone clinical exams.”
GE Healthcare’s PET/CT + MR system consists of two scanning devices, a mobile patient system and the latest image registration application running on the company’s Advantage Workstation*, allowing a patient to be moved from one device (PET/CT) to the other device (MR) without changing positions on the table. GE Healthcare’s PET/CT+ MR technology is designed to accurately capture images and correlate information from PET, CT and MRI imaging technologies.
*Trademark of General Electric Company
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at gehealthcare.com/.